Abstract
MAPKAPK5 has been proposed to play a role in regulation of matrix metalloprotease expression and so to be a potential target for intervention in rheumatoid arthritis. We present here the identification of a series of compounds against this target which are effective in both biochemical and cell assays. The expansion of the series is described, along with early SAR and pharmacokinetics for some representative compounds.
Copyright © 2012 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Antirheumatic Agents / chemical synthesis*
-
Antirheumatic Agents / pharmacokinetics
-
Antirheumatic Agents / pharmacology
-
Arthritis, Rheumatoid / drug therapy
-
Arthritis, Rheumatoid / enzymology
-
Binding Sites
-
High-Throughput Screening Assays
-
Humans
-
Hydrogen Bonding
-
Imidazoles / chemical synthesis*
-
Imidazoles / pharmacokinetics
-
Imidazoles / pharmacology
-
Intracellular Signaling Peptides and Proteins / antagonists & inhibitors*
-
Intracellular Signaling Peptides and Proteins / metabolism
-
Models, Molecular
-
Protein Binding
-
Protein Kinase Inhibitors / chemical synthesis*
-
Protein Kinase Inhibitors / pharmacokinetics
-
Protein Kinase Inhibitors / pharmacology
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Protein Serine-Threonine Kinases / metabolism
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / pharmacokinetics
-
Pyrazoles / pharmacology
-
Rats
-
Small Molecule Libraries
-
Structure-Activity Relationship
Substances
-
Antirheumatic Agents
-
Imidazoles
-
Intracellular Signaling Peptides and Proteins
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Small Molecule Libraries
-
MAP-kinase-activated kinase 5
-
Protein Serine-Threonine Kinases